ES8801582A1 - Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2). - Google Patents

Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).

Info

Publication number
ES8801582A1
ES8801582A1 ES556785A ES556785A ES8801582A1 ES 8801582 A1 ES8801582 A1 ES 8801582A1 ES 556785 A ES556785 A ES 556785A ES 556785 A ES556785 A ES 556785A ES 8801582 A1 ES8801582 A1 ES 8801582A1
Authority
ES
Spain
Prior art keywords
lymphokine
growth
monoclonal antibody
antioncotic
cytotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556785A
Other languages
English (en)
Other versions
ES556785A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59236357A external-priority patent/JPS61115099A/ja
Priority claimed from JP59236356A external-priority patent/JPH0811759B2/ja
Priority claimed from JP60028396A external-priority patent/JPS61115026A/ja
Priority claimed from JP60166754A external-priority patent/JPS61115028A/ja
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of ES8801582A1 publication Critical patent/ES8801582A1/es
Publication of ES556785A0 publication Critical patent/ES556785A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

METODO DE PREPARACION DE COMPOSICIONES FARMACEUTICAS A BASE DE LINFOCINA(LK2). CONSISTE EN DISOLVER AL MENOS 5D105 UNIDADES DE LINFOCINA(LK2) EN SUERO SALINO; FILTRAR EN CONDICIONES ESTERILES LA DISOLUCION RESULTANTE MEDIANTE UN FILTRO DE MEMBRANA; INTRODUCIR EL FILTRADO EN VIALES Y LIOFILIZARLO; Y SELLAR LOS VIALES. ESTAS COMPOSICIONES TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DEL CANCER DE PECHO, CARCINOMA DE PULMON, CARCINOMA DE HIGADO Y LEUCEMIA.
ES556785A 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2). Expired ES8801582A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP59236357A JPS61115099A (ja) 1984-11-09 1984-11-09 モノクロ−ナル抗体とその製法
JP59236356A JPH0811759B2 (ja) 1984-11-09 1984-11-09 新リンホカイン▲ｉｉ▼とその製法および用途
JP60028396A JPS61115026A (ja) 1985-02-18 1985-02-18 新リンホカイン２の製造方法
JP60166754A JPS61115028A (ja) 1985-07-30 1985-07-30 抗腫瘍効果増強剤

Publications (2)

Publication Number Publication Date
ES8801582A1 true ES8801582A1 (es) 1988-02-16
ES556785A0 ES556785A0 (es) 1988-02-16

Family

ID=27458873

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548727A Expired ES8703161A1 (es) 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2)
ES556785A Expired ES8801582A1 (es) 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES548727A Expired ES8703161A1 (es) 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2)

Country Status (11)

Country Link
US (4) US5019385A (es)
KR (1) KR930004596B1 (es)
AT (1) AT395017B (es)
AU (1) AU603053B2 (es)
CH (1) CH664574A5 (es)
DE (1) DE3539775C2 (es)
ES (2) ES8703161A1 (es)
FR (1) FR2572936B1 (es)
GB (1) GB2168355B (es)
IT (1) IT1184668B (es)
SE (1) SE468853B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
AU2001236807A1 (en) * 2000-02-10 2001-08-20 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US9107879B1 (en) * 2010-04-01 2015-08-18 Vanderbilt University Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164964A (en) * 1967-04-20 1969-09-24 Ceskoslovenska Akademie Ved A Method of Cultivation of Animal Cells, and Apparatus for Carrying Out the Said Method.
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
DE3378128D1 (en) * 1982-04-20 1988-11-03 Sloan Kettering Inst Cancer Purification of interleukin 2
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
JPS5939832A (ja) * 1982-08-28 1984-03-05 Ajinomoto Co Inc モノクロ−ナル抗体ならびにその製法、使用法
EP0111344A2 (en) * 1982-12-13 1984-06-20 Sloan-Kettering Institute For Cancer Research Anti-interleukin-2 monoclonal antibodies
DE3329449A1 (de) * 1983-08-16 1985-03-07 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Monoklonaler antikoerper, der eine struktur erkennt, die dem human-interleukin-2 (tcgf) und der leichten kette (lambda) von humanimmunglobulin gemeinsam ist, und hybridoma-zell-linien, die diese monoklonalen antikoerper produzieren
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
WO1986004587A1 (en) * 1985-02-05 1986-08-14 Cetus Corporation Purification of native colony stimulating factor-1

Also Published As

Publication number Publication date
IT8548762A0 (it) 1985-11-08
KR860006268A (ko) 1986-09-09
ES8703161A1 (es) 1987-02-01
US5002878A (en) 1991-03-26
IT1184668B (it) 1987-10-28
AU603053B2 (en) 1990-11-08
GB8527466D0 (en) 1985-12-11
FR2572936A1 (fr) 1986-05-16
DE3539775A1 (de) 1986-11-06
CH664574A5 (fr) 1988-03-15
ES556785A0 (es) 1988-02-16
US5003048A (en) 1991-03-26
SE8505286D0 (sv) 1985-11-08
DE3539775C2 (de) 1994-05-26
GB2168355B (en) 1989-04-19
AT395017B (de) 1992-08-25
US5030564A (en) 1991-07-09
SE8505286L (sv) 1986-05-10
AU4970885A (en) 1986-05-15
KR930004596B1 (ko) 1993-06-01
GB2168355A (en) 1986-06-18
US5019385A (en) 1991-05-28
ATA327685A (de) 1992-01-15
SE468853B (sv) 1993-03-29
FR2572936B1 (fr) 1990-07-20
ES548727A0 (es) 1987-02-01

Similar Documents

Publication Publication Date Title
KR880701736A (ko) Il-6의 제조방법 및 용도
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
ATE58554T1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
IT1194043B (it) Produzione dell'ormone bovino della crescita mediante microorganismi
IT1148022B (it) Procedimento per la produzione del fattore di stimolo della differenziazione cellulare nell'uomo
AU579812B2 (en) Cell lines and their use for the production of proteins
GB8726077D0 (en) Proteins
ES480535A1 (es) Procedimiento mejorado para la preparacion de interferon.
ES8801582A1 (es) Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).
FR2539759B1 (fr) Nouvelles lignees de cellules utilisables dans la preparation de cellules d'hybridome
EP0195910A3 (en) Process to reduce the molecular-weight distribution of polytetrahydrofuran
IT1234977B (it) Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
FR2534273B1 (fr) Lignees cellulaires originaires de mammiferes superieurs, productrices d'hormone de croissance, de preference humaine, et vecteurs pour leur obtention
EP0229289A3 (en) Method of culturing animal cells
PL214277A1 (pl) Sposob wytwarzania agregatow bakteryjnych komorek o zwiekszonej twardosci czastek
FI882059A (fi) Menetelmä vierasproteiinien valmistamiseksi Streptomycessoluissa
AU1089983A (en) Interfacial growth of cells in tissue culture
DE3566936D1 (en) Process for the production of active anode materials for use in cells
EP0148770A3 (en) Composition for cell cultivation, production and use thereof
BE887391A (fr) Procede pour la preparation d'alcaloides de l'ergot de seigle, en particulier de l'ergocornine et de la beta-ergryptine
ES2013123A6 (es) Un procedimiento para la preparacion de oxidos de 1,2,4-benzotriazina.
SU1031367A1 (ru) Способ обработки структур кремний-двуокись кремния
AU6112386A (en) Method for enhancement of growth of human cells in culture
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
CS160983A2 (en) Method of polypetide production with sequence of animal interferon's amino acids